Literature DB >> 25847554

Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - a double blind randomized controlled trial - TAK-MetS trial.

F Amin1, N Islam2, Nfn Anila3, A H Gilani4.   

Abstract

OBJECTIVE: To compare the clinical efficacy of Black seeds and Turmeric alone and its co-administration in lower doses among patients with metabolic syndrome (MetS).
DESIGN: Double-blind-randomized-controlled trial.
SETTING: Hijrat colony, Karachi, Pakistan. INTERVENTION: Apparently healthy males (n=250), who screened positive for MetS, were randomized to either Black seeds (1.5g/day), Turmeric (2.4g/day), its combination (900mg Black seeds and 1.5g Turmeric/day) or placebo for 8 weeks. MAIN OUTCOME MEASURES: body-mass-index (BMI), body-fat-percent (BF%), waist-circumference (WC), hip-circumference (HC), blood pressure (BP), lipid-profile (cholesterol, HDL-cholesterol, LDL-cholesterol and TG), fasting blood glucose (FBG) and c-reactive protein (CRP).
RESULTS: At 4 weeks, compared to baseline, Black seed and Turmeric alone showed improvement in BMI, WC and BF%. Combination improved all parameters except HDL-cholesterol with lower FBG and LDL-cholesterol as compared to placebo. At 8 weeks, compared to placebo, Black seeds reduced lipids and FBG, while Turmeric reduced LDL-cholesterol and CRP. Interestingly, combination group with 60% dose of the individual herbs showed an improvement in all parameters from baseline. When compared to placebo, it reduced BF%, FBG, cholesterol, TG, LDL-cholesterol, CRP and raised HDL-cholesterol.
CONCLUSION: Turmeric and Black seeds showed improvement in all parameters of metabolic syndrome, when co-administered at 60% of doses of individual herbs with enhanced efficacy and negligible adverse-effects. The combination of Black seeds and Turmeric can therefore, be recommended with lifestyle modification as a starting point for patients with MetS to halt its future complications and progression.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Black seeds; Clinical efficacy; Co-administration; Metabolic syndrome; Synergism; Turmeric

Mesh:

Substances:

Year:  2015        PMID: 25847554     DOI: 10.1016/j.ctim.2015.01.008

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  13 in total

1.  Effect of Nigella Sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients.

Authors:  Hebatallah Ahmed Mohamed Moustafa; Lamia Mohamed El Wakeel; Mohamed Reda Halawa; Nagwa Ali Sabri; Alshaymaa Zaki El-Bahy; Abdel Nasser Singab
Journal:  Endocrine       Date:  2019-05-31       Impact factor: 3.633

2.  A Systematic Review and Meta-analysis of Randomized Controlled Trials on the Effects of Turmeric and Curcuminoids on Blood Lipids in Adults with Metabolic Diseases.

Authors:  Fen Yuan; Hui Dong; Jing Gong; Dingkun Wang; Meilin Hu; Wenya Huang; Ke Fang; Xin Qin; Xin Qiu; Xueping Yang; Fuer Lu
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

3.  The Effect of Curcumin Supplemsentation on Anthropometric Indices in Overweight and Obese Individuals: A Systematic Review of Randomized Controlled Trials.

Authors:  Zahra Safari; Mohammad Bagherniya; Gholamreza Askari; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  North African Medicinal Plants Traditionally Used in Cancer Therapy.

Authors:  Jorge M Alves-Silva; Abderrahmane Romane; Thomas Efferth; Lígia Salgueiro
Journal:  Front Pharmacol       Date:  2017-06-26       Impact factor: 5.810

5.  Pharmacological basis for the medicinal use of polyherbal formulation and its ingredients in cardiovascular disorders using rodents.

Authors:  Abdul Malik; Malik Hassan Mehmood; Hajra Channa; Muhammad Shoaib Akhtar; Anwarul-Hassan Gilani
Journal:  BMC Complement Altern Med       Date:  2017-03-07       Impact factor: 3.659

6.  Effects of curcumin on glycemic control and lipid profile in prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Nalinee Poolsup; Naeti Suksomboon; Putu Dian Marani Kurnianta; Kulchalee Deawjaroen
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

Review 7.  Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases.

Authors:  Bahare Salehi; María L Del Prado-Audelo; Hernán Cortés; Gerardo Leyva-Gómez; Zorica Stojanović-Radić; Yengkhom Disco Singh; Jayanta Kumar Patra; Gitishree Das; Natália Martins; Miquel Martorell; Marzieh Sharifi-Rad; William C Cho; Javad Sharifi-Rad
Journal:  J Clin Med       Date:  2020-03-10       Impact factor: 4.241

Review 8.  Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials.

Authors:  Si Qin; Lifan Huang; Jiaojiao Gong; Shasha Shen; Juan Huang; Hong Ren; Huaidong Hu
Journal:  Nutr J       Date:  2017-10-11       Impact factor: 3.271

Review 9.  Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone.

Authors:  Alireza Tavakkoli; Vahid Mahdian; Bibi Marjan Razavi; Hossein Hosseinzadeh
Journal:  J Pharmacopuncture       Date:  2017-09-30

Review 10.  Curcumin and Colorectal Cancer: From Basic to Clinical Evidences.

Authors:  Maria Pricci; Bruna Girardi; Floriana Giorgio; Giuseppe Losurdo; Enzo Ierardi; Alfredo Di Leo
Journal:  Int J Mol Sci       Date:  2020-03-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.